The global coronary stents market was valued at USD 6.68 billion in 2024 and is projected to increase from USD 7.02 billion in 2025 to USD 10.66 billion by 2032, registering a CAGR of 6.2% during the forecast period. In 2024, North America held the largest share of the market, accounting for 33.08%.
The global coronary stents market is experiencing steady growth, driven by the rising prevalence of cardiovascular diseases and the increasing demand for minimally invasive treatment options. Technological advancements in stent design, including drug-eluting and bioresorbable variants, are further enhancing adoption across healthcare systems. North America currently holds a dominant position due to advanced healthcare infrastructure and high procedural volumes, while the Asia-Pacific region is emerging as a rapidly growing market supported by a large patient base and expanding healthcare access.
Learn more here:
**https://www.fortunebusinessinsights.com/industry-reports/coronary-stents-market-100065**
Market Segmentation
The coronary stents market is segmented by product type, material, mode of delivery, and end-user. Product types include bare-metal stents, drug-eluting stents, and bioresorbable stents. Materials used range from metallic alloys to polymer-based structures designed for biocompatibility. The market is also categorized by delivery methods, such as balloon-expandable and self-expanding stents. End-users primarily include hospitals, specialty cardiac centers, and ambulatory surgical centers.
List Of Key Coronary Stents Companies Profiled:
Market Growth Drivers